PTC Therapeutics Reports Third Quarter 2019 Financial Results and Provides a Corporate Update

SOUTH PLAINFIELD, N.J., Oct. 29, 2019 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced a corporate update and reported financial results for the third quarter ending September 30, 2019.

The Friedreich ataxia program continues to advance with an IND submission now expected in mid-2020.

PTC Therapeutics Reports Third Quarter 2019 Financial Results and Provides a Corporate Update